Home

Subscription

May 2017 issue

April 1, 2017 issue

March 2017 issue

February 2017 issue

January 2017 issue



BACK ISSUES

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006


2016 Issues

December 2016 Issue
• Peace and Good Will
• New Drug Review: Lixisenatide (Adlyxin – Sanofi)
• Appreciation
• Index for Volume 11, 2016


November 2016 Issue
• Feature: You Say Adherence and I Say Compliance – Whatever We Call It, Pharmacists, with Our Patients, Must Respond to this Challenge!
• New Drug Review: Lifitegrast (Xiidra – Shire)


October 2016 Issue
• Feature: Understanding and Reducing Drug Prices Must Start with Transparency
• New Drug Review: Insulin degludec (Tresiba – Novo Nordisk)


September 2016 Issue
• Feature: Our Profession and Our Patients Need Independent Pharmacists! But Can We Keep Them?

August 2016 Issue
• Feature: The PBM Formulary Follies
• New Drug Review: Pimavanserin tartrate (Nuplazid – Acadia)


July 2016 Issue
• Feature: CVS has an Exceptional Opportunity but Rejects It – To the Peril of its Customers and Frustration and Risk of its Pharmacists!
• New Drug Review: Brivaracetam (Briviact – UCB)


June 2016 Issue
• Feature: Physician-Assisted Suicide - Can we not care best for our patients by walking with them in the dying instead of leading them to it?
• New Therapeutic Agents Marketed in the United States in 2015


May 2016 Issue
• Feature: OUTRAGES! – But Some With Opportunities!
• New Drug Review: Lesinurad (Zurampic – AstraZeneca; Ironwood)


April 2016 Issue
• Feature: The FDA Should Provide Pharmacists with the Authority to Dispense Chantix Without a Prescription
• New Drug Review: Cariprazine hydrochloride (Vraylar – Allergan)


March 2016 Issue
• Feature: Prescription Drug Prices – Billions for Pharmaceutical Companies, Insurance Companies, and PBMs, but Pennies for Pharmacies
• New Drug Review: Eluxadoline (Viberzi – Allergan)


February 2016 Issue
• Feature: Is Walgreens Valeant's New Philidor?
• New Drug Review: Mepolizumab (Nucala – GlaxoSmithKline)


January 2016 Issue
• Feature: Pharmacy Must Have a More Effective Organizational Structure! - The United Pharmacists of America
• New Drug Review: Ledipasvir/sofosbuvir (Harvoni – Gilead Sciences)
• New Drug Review: Secukinumab (Cosentyx – Novartis)